Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Ruzinurad (SHR4640) in Healthy Volunteers
NCT04620408Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Dec 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ruzinurad in hyperuricemia and gout (2 arms), sponsored by Hengrui. Primary endpoints: Peak Plasma Concentration at Day 11, Area Under the Curve to Last Timepoint at Day 11 and 1 more. Status: unknown.
02
Drugs
ruzinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT04620408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620408.